Progesterone Industry Trends, Growth, Value, Segment Analysis with Forecast Import and Export Analysis 2029

This growth is driven by increased awareness and diagnosis of hormone-related disorders, such as polycystic ovary syndrome (PCOS), infertility, and menstrual irregularities. According to the World Health Organization (WHO), in 2023, PCOS affected an estimated 8 to 13% of reproductive-aged women, with up to 70% of these women remaining undiagnosed globally. As a result, healthcare providers are increasingly prescribing progesterone medications to manage these conditions. Additionally, the aging population and the rise in menopausal symptoms are fueling the demand for hormone replacement therapies.

Advancements in pharmaceutical formulations and drug delivery technologies are enhancing the efficacy and safety of progesterone products, promoting their use in clinical settings. Innovations such as sustained-release formulations and transdermal patches offer convenient administration routes and improved patient compliance. Expanding research into the therapeutic potential of progesterone in areas like cancer treatment, neurology, and psychiatry will further drive market growth.

According to the report, the global progesterone market size was worth around USD 1027.2 million in 2023 and is predicted to grow to around USD 2137.9 million by 2029 with a compound annual growth rate (CAGR) of roughly 13.3 % between 2024 and 2029

The progesterone industry is segmented by formulation, route of administration, application, drug type, type, distribution channel, and region.

By application, the contraception segment is expected to grow at a 13.1% CAGR from 2024 to 2032. This growth is driven by the increasing global focus on family planning and the growing acceptance of hormonal contraceptives among women. Continued R&D efforts to improve the safety, efficacy, and convenience of progesterone-based contraceptives are creating lucrative opportunities for manufacturers and stakeholders.

In terms of type, the over-the-counter (OTC) segment is projected to grow at a 12.4% CAGR during the same period. This growth is supported by rising consumer awareness and empowerment regarding women’s health, along with the convenience of accessing OTC products. The availability of progesterone creams, gels, and supplements without a prescription enhances autonomy in managing hormone-related conditions, thereby expanding the consumer base.

The Asia-Pacific progesterone market is expected to grow at a rate of 12.3% through 2032. This growth is attributed to the burgeoning population, increased awareness, and improved access to healthcare services for hormone-related disorders like PCOS and infertility. Cultural shifts towards smaller family sizes and delayed childbearing are contributing to the rising adoption of hormonal contraceptives containing progesterone. Additionally, a robust pharmaceutical manufacturing sector in countries like India and China will support local production of progesterone medications, ensuring supply chain resilience and affordability, thereby stimulating regional industry growth.

Progesterone Market Companies

The major players operating in the progesterone industry are as mentioned below:

• Alkem Laboratories Ltd.
• Aquatic Group
• Bionpharma Inc.
• Cadila Pharmaceuticals
• Cipla Inc.
• Estrellas Life Sciences Private Limited.
• Eli Lily & Company
• Glenmark Pharmaceuticals Ltd.
• Insud Pharma S.L.U.
• Lupin
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Ltd

Market, By Formulation

• Natural
• Synthetic

Market, By Route of Administration

• Injectable
• Oral
• Transdermal
• Other routes of administration

Market, By Application

• Menopause
• Contraception
• Dysfunctional uterine bleeding
• Hyperplastic precursor lesions
• Endometrial cancer
• Other applications

Market, By Drug Type

• Branded
• Generic

Market, By Type

• Prescription
• OTC

Market, By Distribution Channel

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

Regional Analysis:

• North America
  • U.S.
  • Canada

• Europe

  • Rest of Europe

• Asia Pacific

  • Rest of Asia Pacific

• Latin America

  Rest of Latin America

• Middle East and Africa
  • Rest of Middle East and Africa